Bank of America
AGN.PRA

Bank of America’s Allergan plc AGN.PRA Stock Holding History

Bank of America’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40,671
Closed -$23.8M – 7552
2017
Q4 		$23.8M Buy
40,671
+26,830
+194% +$17.3M ﹤0.01% 1663
2017
Q3 		$10.2M Buy
13,841
+866
+7% +$719K ﹤0.01% 2495
2017
Q2 		$11.3M Sell
12,975
-1,924
-13% -$1.61M ﹤0.01% 2247
2017
Q1 		$12.6M Sell
14,899
-7,045
-32% -$5.84M ﹤0.01% 2175
2016
Q4 		$16.7M Sell
21,944
-12,538
-36% -$9.48M ﹤0.01% 1832
2016
Q3 		$28.3M Buy
34,482
+22,524
+188% +$19.5M 0.01% 1381
2016
Q2 		$9.97M Sell
11,958
-14,666
-55% -$12.2M ﹤0.01% 2192
2016
Q1 		$24.5M Sell
26,624
-2,363
-8% -$2.26M 0.01% 1408
2015
Q4 		$29.8M Buy
28,987
+14,140
+95% +$14.2M 0.01% 1330
2015
Q3 		$14M Buy
14,847
+13,332
+880% +$13.9M ﹤0.01% 1910
2015
Q2 		$1.58M Buy
+1,515
New +$1.59M ﹤0.01% 3703

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Bank of America's AGN.PRA Position: Q1 2018 in Review

Bank of America sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 40,671 shares — an estimated $23.8M sold.

Bank of America first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $29.8M in Q4 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Bank of America reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Bank of America sold 40,671 Allergan plc shares in Q1 2018, an estimated $23.8M.
  • Bank of America first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Bank of America's Allergan plc position peaked at $29.8M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.